Methocarbamol use is associated with decreased hospital length of stay in trauma patients with closed rib fractures

Asad E Patanwala, Ohoud Aljuhani, Brian J. Kopp, Brian L Erstad

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: The objective of this study was to evaluate the effect of methocarbamol on hospital length of stay in patients with closed rib fracture injuries. Methods: This was a retrospective cohort study conducted in an academic medical center in the United States. Adult trauma patients, who sustained closed rib fractures, were included. Patients were categorized based on whether they received methocarbamol or not during admission. The primary outcome of interest was time to hospital discharge in days (i.e. length of hospital stay). A Cox Proportional Hazards Model was constructed to determine if methocarbamol use was associated with a greater likelihood of earlier discharge. Results: A total of 592 patients were included in the final study cohort. Of these, 329 received methocarbamol and 263 did not receive methocarbamol. In the Cox Proportional Hazards Model methocarbamol use was associated with a greater likelihood of being discharged from the hospital (HR 1.47, 95% CI 1.21 to 1.78, p < 0.001). Conclusions: The use of methocarbamol after traumatic rib fractures may result in a reduction in the length of hospital stay. Summary: Methocarbamol may improve patient recovery after rib fractures by decreasing intercostal muscle spasm. This may decrease time to hospital discharge and pulmonary complications in patients with rib fractures.

Original languageEnglish (US)
JournalAmerican Journal of Surgery
DOIs
StateAccepted/In press - May 23 2016

Fingerprint

Methocarbamol
Rib Fractures
Closed Fractures
Length of Stay
Wounds and Injuries
Proportional Hazards Models
Cohort Studies
Intercostal Muscles
Spasm
Retrospective Studies

Keywords

  • Central
  • Methocarbamol
  • Muscle relaxants
  • Neuromuscular agents
  • Wounds and injuries

ASJC Scopus subject areas

  • Surgery

Cite this

@article{1d2da44573d54960a47d92ea9d240380,
title = "Methocarbamol use is associated with decreased hospital length of stay in trauma patients with closed rib fractures",
abstract = "Background: The objective of this study was to evaluate the effect of methocarbamol on hospital length of stay in patients with closed rib fracture injuries. Methods: This was a retrospective cohort study conducted in an academic medical center in the United States. Adult trauma patients, who sustained closed rib fractures, were included. Patients were categorized based on whether they received methocarbamol or not during admission. The primary outcome of interest was time to hospital discharge in days (i.e. length of hospital stay). A Cox Proportional Hazards Model was constructed to determine if methocarbamol use was associated with a greater likelihood of earlier discharge. Results: A total of 592 patients were included in the final study cohort. Of these, 329 received methocarbamol and 263 did not receive methocarbamol. In the Cox Proportional Hazards Model methocarbamol use was associated with a greater likelihood of being discharged from the hospital (HR 1.47, 95{\%} CI 1.21 to 1.78, p < 0.001). Conclusions: The use of methocarbamol after traumatic rib fractures may result in a reduction in the length of hospital stay. Summary: Methocarbamol may improve patient recovery after rib fractures by decreasing intercostal muscle spasm. This may decrease time to hospital discharge and pulmonary complications in patients with rib fractures.",
keywords = "Central, Methocarbamol, Muscle relaxants, Neuromuscular agents, Wounds and injuries",
author = "Patanwala, {Asad E} and Ohoud Aljuhani and Kopp, {Brian J.} and Erstad, {Brian L}",
year = "2016",
month = "5",
day = "23",
doi = "10.1016/j.amjsurg.2017.01.003",
language = "English (US)",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Methocarbamol use is associated with decreased hospital length of stay in trauma patients with closed rib fractures

AU - Patanwala, Asad E

AU - Aljuhani, Ohoud

AU - Kopp, Brian J.

AU - Erstad, Brian L

PY - 2016/5/23

Y1 - 2016/5/23

N2 - Background: The objective of this study was to evaluate the effect of methocarbamol on hospital length of stay in patients with closed rib fracture injuries. Methods: This was a retrospective cohort study conducted in an academic medical center in the United States. Adult trauma patients, who sustained closed rib fractures, were included. Patients were categorized based on whether they received methocarbamol or not during admission. The primary outcome of interest was time to hospital discharge in days (i.e. length of hospital stay). A Cox Proportional Hazards Model was constructed to determine if methocarbamol use was associated with a greater likelihood of earlier discharge. Results: A total of 592 patients were included in the final study cohort. Of these, 329 received methocarbamol and 263 did not receive methocarbamol. In the Cox Proportional Hazards Model methocarbamol use was associated with a greater likelihood of being discharged from the hospital (HR 1.47, 95% CI 1.21 to 1.78, p < 0.001). Conclusions: The use of methocarbamol after traumatic rib fractures may result in a reduction in the length of hospital stay. Summary: Methocarbamol may improve patient recovery after rib fractures by decreasing intercostal muscle spasm. This may decrease time to hospital discharge and pulmonary complications in patients with rib fractures.

AB - Background: The objective of this study was to evaluate the effect of methocarbamol on hospital length of stay in patients with closed rib fracture injuries. Methods: This was a retrospective cohort study conducted in an academic medical center in the United States. Adult trauma patients, who sustained closed rib fractures, were included. Patients were categorized based on whether they received methocarbamol or not during admission. The primary outcome of interest was time to hospital discharge in days (i.e. length of hospital stay). A Cox Proportional Hazards Model was constructed to determine if methocarbamol use was associated with a greater likelihood of earlier discharge. Results: A total of 592 patients were included in the final study cohort. Of these, 329 received methocarbamol and 263 did not receive methocarbamol. In the Cox Proportional Hazards Model methocarbamol use was associated with a greater likelihood of being discharged from the hospital (HR 1.47, 95% CI 1.21 to 1.78, p < 0.001). Conclusions: The use of methocarbamol after traumatic rib fractures may result in a reduction in the length of hospital stay. Summary: Methocarbamol may improve patient recovery after rib fractures by decreasing intercostal muscle spasm. This may decrease time to hospital discharge and pulmonary complications in patients with rib fractures.

KW - Central

KW - Methocarbamol

KW - Muscle relaxants

KW - Neuromuscular agents

KW - Wounds and injuries

UR - http://www.scopus.com/inward/record.url?scp=85009473645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009473645&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2017.01.003

DO - 10.1016/j.amjsurg.2017.01.003

M3 - Article

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

ER -